XML 59 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Note 4 - Cash, Cash Equivalents and Marketable Securities (10Q)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Notes to Financial Statements    
Cash, Cash Equivalents, and Marketable Securities [Text Block]

4.

Cash, cash equivalents and marketable securities

 

The following is a summary of the Company's cash and cash equivalents as of the date indicated:

 

   

March 31, 2023

   

December 31,

2022

 
                 

Cash in banking institutions

  $ 631,002     $ 1,586,920  

Money market funds

    14,014,584       8,526,786  

Total

  $ 14,645,586     $ 10,113,706  

 

The following is a summary of the Company's marketable securities as of as of the date indicated:

 

   

Amortized cost

   

Unrealized

gains

   

Unrealized

losses

   

Fair Value

 
                                 

March 31, 2023

                               

Commercial paper

  $ 1,995,318       210     $ (1,437 )   $ 1,994,091  

U.S. treasury bonds

    999,575             (1,896 )     997,679  

Total

  $ 2,994,893       210     $ (3,333 )   $ 2,991,770  
                                 

December 31, 2022

                               

Commercial paper

  $ 9,445,220       263     $ (21,313 )   $ 9,424,170  

U.S. treasury bonds

    2,999,095             (14,325 )     2,984,770  

Total

  $ 12,444,315       263     $ (35,638 )   $ 12,408,940  

 

The Company's marketable securities generally have contractual maturity dates between 7 and 30 months.

 

As of March 31, 2023, $1,991,770 of the marketable securities held were in an unrealized loss position, all of which have been in an unrealized loss position for less than twelve months. The Company determined that unrealized losses on marketable securities were primarily due to market conditions, including changes in the U.S. Federal Reserve interest rate, and not credit losses. The Company does not intend to sell the investments and it is not more likely than not that that the Company will be required to sell the investments before the recovery of the amortized cost basis. No allowance for credit losses related to any of these securities was recorded for the three months ended March 31, 2023.

4. Cash, cash equivalents and marketable securities

 

The following is a summary of the Company's cash and cash equivalents as of the dates indicated:

 

   

December 31,

 
   

2022

   

2021

 

Cash in banking institutions

  $ 1,586,920     $ 30,308,075  

Money market funds

    8,526,786       7,005,483  

Total

  $ 10,113,706     $ 37,313,558  

 

The following is a summary of the Company's marketable securities as of December 31, 2022:

 

   

Amortized cost

   

Unrealized

gains

   

Unrealized

losses

   

Fair Value

 
                                 

Commercial paper

  $ 9,445,220     $ 263     $ (21,313 )   $ 9,424,170  

U.S. treasury bonds

    2,999,095             (14,325 )     2,984,770  

Total

  $ 12,444,315     $ 263     $ (35,638 )   $ 12,408,940  

 

The Company did not have any marketable securities as of December 31, 2021. The Company's marketable securities generally have contractual maturity dates between 3 and 12 months. All but one of the Company’s marketable securities are in an unrealized loss position at December 31, 2022. Unrealized losses on marketable securities as of December 31, 2022 were $35,638 and were primarily due to changes in interest rates, and not due to increased credit risks associated with specific securities. Accordingly, no other-than-temporary impairment was recorded for the year ended December 31, 2022 and there were no realized gains or losses recorded during the year ended December 31, 2022.